The group notably revealed a steady rise in its average occupancy rate, which reached 89.1%, representing a 2.1-point year-on-year increase. Over two years, the recovery is even more striking, with a 4.1-point gain.

Revenue: favorable price and volume effects

At the end of March, emeis recorded organic revenue growth of 6.3% (compared to +6.1% in 2025), reaching 1.509 billion euros. This performance was fueled by two levers: the price effect, thanks to an average revaluation of 3.9% across all regions, and international momentum. While France grew by 4.8%, international operations drove growth with a 7.3% organic increase.

The clinics division also showed encouraging signs, with a 4.9% increase over the quarter.

Outlook: emeis confirms its 2026 ambitions

On the back of this strong start to the year, management confirmed its short- and medium-term financial targets. For the 2026 fiscal year, the Group anticipates like-for-like Ebitdar (EBITDA before rent) growth exceeding 10%.

In the longer term, the 2024-2028 trajectory was reiterated, with a target average annual Ebitdar growth of between 12% and 16%.